Strategic advisory

A PARTNER TO HELP CRAFT AND TELL YOUR STORY

Investor Relations

We know what investors look for

Our clients are leaders and innovators in their fields. Our mission is to enable them to convey their story and opportunity in a transparent, credible, and consistent way to the investment community and potential business partners. Knowing how to effectively communicate how technology advantages, biological and clinical relevance results in a large TAM opportunity is our expertise. 

Our investor relations programs are highly customized and designed for consistent, pro-active outreach to the financial community with a strategy in place at the outset. We strive to efficiently utilize management’s time and resources to maximize interactions with the right investors for the story.

Public offering Advisory

WE KNOW WHEN YOU'RE READY

Proficient in the capital markets for life science tools and diagnostics companies and having worked on underwriting teams with all of the U.S. bulge-bracket banks, MedDx’s professionals have a unique perspective on your reality of a successful IPO or SPAC transaction. MedDx’s IPO advisory services help clients and their board’s evaluate the appropriateness of an initial public offering and efficiently organize the process. We assist in the selection of lead underwriters by introducing leading equity research analysts, making sense of conflicting league tables, coordinating bake-off’s, and negotiating underwriting spreads.

Corporate Strategy & Development

INTRODUCING YOU TO VALUABLE COMMERCIAL RELATIONSHIPS

MedDx’s corporate partnering process consists of a series of strategies and tactics:

Mergers & Acquisitions

MedDx’s focus on the diagnostics industry and dialogue with key industry thought leaders, and proprietary database, equips us with an important competitive edge compared to other investment banking firms.

CAPITAL MARKETS

MedDx has deep experience advising clients on private placements of equity with venture capital firms (typically early stage or private companies) and PIPEs with institutional investors (for public companies) in the United States.

HOW CAN WE HELP?